Form 4: Inotiv Inc. Executive Andrea Castetter Reports Stock Option Grant

Andrea Castetter, SVP, Gen. Counsel & Secretary of Inotiv, Inc., reports the acquisition of 10,000 employee stock options.

Summary

• On January 15, 2025, Andrea Castetter, SVP, Gen. Counsel & Secretary of Inotiv, Inc., was granted 10,000 non-qualified employee stock options.
• The exercise price of these options is $4.2025.
• The options vest over three years, with 40% vesting on the first anniversary of the grant date, followed by 30% in each of the subsequent two years, contingent upon continued employment.
• The options expire on January 15, 2035.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. The grant of stock options is a routine event, but it signals confidence in the executive and aligns their interests with shareholders.

Positives

• The grant of stock options aligns the executive's interests with those of the shareholders, incentivizing performance and long-term value creation.
• The vesting schedule encourages continued employment and commitment to the company's success.

Future Outlook

The document does not contain any specific forward-looking statements regarding the company's future performance.

Industry Context

Stock option grants are a common form of executive compensation in the biotechnology and pharmaceutical services industry, used to attract and retain talent and align their interests with those of shareholders.

Comparison to Industry Standards

• Stock option grants are a standard component of executive compensation packages in the pharmaceutical and biotechnology industries.
• Companies like Charles River Laboratories and Envigo (now part of Inotiv) also utilize stock options as part of their compensation strategy.
• The vesting schedule of 40%/30%/30% over three years is fairly typical for such grants.

Stakeholder Impact

• Shareholders may view the stock option grant positively as it incentivizes the executive to improve company performance.
• Employees may see it as a positive sign of investment in leadership.

Key Dates